https://www.michaeljfox.org/grant/dipraglurant-levodopa-induced-dyskinesia-pre-phase-iib-studies
Dipraglurant for Levodopa-Induced Dyskinesia Pre-phase IIB Studies | Parkinson's Disease
Study Rationale: Dipraglurant is a modulator of the metabotropic glutamate receptor 5 (mGluR5). Blockade of this receptor has been shown to have...
levodopa induced dyskinesia